Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

220 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Multiple sclerosis: is multiple sclerosis caused by venous insufficiency?
Rudick RA. Rudick RA. Nat Rev Neurol. 2010 Sep;6(9):472-4. doi: 10.1038/nrneurol.2010.117. Nat Rev Neurol. 2010. PMID: 20811464 No abstract available.
Disease modifying therapies in multiple sclerosis.
Fox RJ, Fisher E, Rudick R. Fox RJ, et al. Neurology. 2002 Aug 13;59(3):471-2; author reply 472-3. doi: 10.1212/wnl.59.3.471. Neurology. 2002. PMID: 12177396 No abstract available.
Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis.
Hardmeier M, Wagenpfeil S, Freitag P, Fisher E, Rudick RA, Kooijmans-Coutinho M, Clanet M, Radue EW, Kappos L; European rIFN beta-1a in Relapsing MS Dose Comparison Trial Study Group. Hardmeier M, et al. Arch Neurol. 2003 Dec;60(12):1736-9. doi: 10.1001/archneur.60.12.1736. Arch Neurol. 2003. PMID: 14676048
Multiple sclerosis: disease markers accelerate progress.
Fox RJ, Rudick RA. Fox RJ, et al. Lancet Neurol. 2004 Jan;3(1):10. doi: 10.1016/s1474-4422(03)00610-0. Lancet Neurol. 2004. PMID: 14693099 Review. No abstract available.
Defining interferon beta response status in multiple sclerosis patients.
Rudick RA, Lee JC, Simon J, Ransohoff RM, Fisher E. Rudick RA, et al. Ann Neurol. 2004 Oct;56(4):548-55. doi: 10.1002/ana.20224. Ann Neurol. 2004. PMID: 15389896 Clinical Trial.
Primary progressive multiple sclerosis as a phenotype of a PLP1 gene mutation.
Warshawsky I, Rudick RA, Staugaitis SM, Natowicz MR. Warshawsky I, et al. Ann Neurol. 2005 Sep;58(3):470-3. doi: 10.1002/ana.20601. Ann Neurol. 2005. PMID: 16130097
Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity.
Bermel RA, Puli SR, Rudick RA, Weinstock-Guttman B, Fisher E, Munschauer FE 3rd, Bakshi R. Bermel RA, et al. Arch Neurol. 2005 Sep;62(9):1371-6. doi: 10.1001/archneur.62.9.1371. Arch Neurol. 2005. PMID: 16157744 Free PMC article. Clinical Trial.
Drug Insight: interferon treatment in multiple sclerosis.
Marrie RA, Rudick RA. Marrie RA, et al. Nat Clin Pract Neurol. 2006 Jan;2(1):34-44. doi: 10.1038/ncpneuro0088. Nat Clin Pract Neurol. 2006. PMID: 16932519 Review.
Imaging correlates of axonal swelling in chronic multiple sclerosis brains.
Fisher E, Chang A, Fox RJ, Tkach JA, Svarovsky T, Nakamura K, Rudick RA, Trapp BD. Fisher E, et al. Ann Neurol. 2007 Sep;62(3):219-28. doi: 10.1002/ana.21113. Ann Neurol. 2007. PMID: 17427920
220 results
Jump to page